RETRACTED: El-Far et al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990

MLA

Ali H. El-Far, et al. “RETRACTED: El-Far et Al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990.” Biomedicines, vol. 12, no. 10, Oct. 2024, p. 2305. EBSCOhost, https://doi.org/10.3390/biomedicines12102305.

APA

Ali H. El-Far, Kavitha Godugu, Taher A. Salaheldin, Noureldien H. E. Darwish, Amna A. Saddiq, & Shaker A. Mousa. (2024). RETRACTED: El-Far et al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990. Biomedicines, 12(10), 2305. https://doi.org/10.3390/biomedicines12102305

Chicago

Ali H. El-Far, Kavitha Godugu, Taher A. Salaheldin, Noureldien H. E. Darwish, Amna A. Saddiq, and Shaker A. Mousa. 2024. “RETRACTED: El-Far et Al. Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 2021, 9, 990.” Biomedicines 12 (10): 2305. doi:10.3390/biomedicines12102305.